TY  - JOUR 
AU  - Qureshi, N.
AU  - Antoniou, S.
AU  - Cornel, J.H.
AU  - Schiele, F.
AU  - Perrone-Filardi, P.
AU  - Brachmann, J.
AU  - Sidelnikov, E.
AU  - Villa, G.
AU  - Ferguson, S.
AU  - Rowlands, C.
AU  - González Juanatey, José Ramón
PY  - 2023
SN  - 1865-8652
UR  - http://hdl.handle.net/20.500.11940/21449
AB  - Introduction: The 2019 European Society of Cardiology and European Atherosclerosis Society (2019 ESC/EAS) guidelines stress the importance of managing low-density lipoprotein cholesterol (LDL-C) after myocardial infarction (MI) to reduce the risk of...
LA  - eng
KW  - Humans
KW  - Anticholesteremic Agents
KW  - Cholesterol, LDL
KW  - Critical Pathways
KW  - Cross-Sectional Studies
KW  - Ezetimibe
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Myocardial Infarction
KW  - Physicians
TI  - European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction
DO  - 10.1007/s12325-022-02344-6
T2  - Advances in Therapy
M2  - 233
KW  - AS Santiago
KW  - CHUS
VL  - 40
ER  -